The overall mission of the Biostatistics and Data Management Core (Core G) is to encourage and facilitate high quality innovative, interdisciplinary and translational HIV/AIDS research through effective data management and by supporting the use of rigorous statistical and analytic methodologies;provide educational opportunities for HIV/AIDS researchers on the Penn campus in the use of statistical approaches; assist in building capacity locally and with International partners;and support the overall strategic plan and mission of the Penn CFAR. To achieve these goals, the Specific Aims of the Biostatistics and Data Management Core G are to: A.1. Advise CFAR Investigators on study design and data analysis issues. A.2. Provide statistical collaboration for research funding applications. A.3. Maintain, and facilitate access to, a clinical care database for use in studying the epidemiology of HIV/AIDS, for evaluating feasibility of intervention studies and for facilitating conduct of such studies. A.4. Provide support for design and testing of data collection instruments, data management, and database development. A.5. Provide training in statistical methods to CFAR investigators and our international partners. A.6. Partner with other Cores and specific Programs of the CFAR in interdisciplinary initiatives as well as other CFARs in support of joint goals.

Public Health Relevance

Core G supports CFAR investigators'ability to carry out high quality innovative and translational research by maintaining a clinical database and by providing expertise and education in study design and the use of rigorous statistical and analytical techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-15
Application #
8505352
Study Section
Special Emphasis Panel (ZAI1-SV-A)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
15
Fiscal Year
2013
Total Cost
$205,667
Indirect Cost
$84,795
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Vadrevu, Surya Kumari; Trbojevic-Akmacic, Irena; Kossenkov, Andrew V et al. (2018) Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy. J Leukoc Biol 104:461-471
Loy, Dorothy E; Plenderleith, Lindsey J; Sundararaman, Sesh A et al. (2018) Evolutionary history of human Plasmodium vivax revealed by genome-wide analyses of related ape parasites. Proc Natl Acad Sci U S A 115:E8450-E8459
Dean, Lorraine T; Schmitz, Kathryn H; Frick, Kevin D et al. (2018) Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA. J Cancer Surviv 12:306-315
Bui, Kevin D; Johnson, Michelle J (2018) Designing robot-assisted neurorehabilitation strategies for people with both HIV and stroke. J Neuroeng Rehabil 15:75
Hogan, Michael J; Conde-Motter, Angela; Jordan, Andrea P O et al. (2018) Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization. Virology 514:106-117
Salantes, D Brenda; Zheng, Yu; Mampe, Felicity et al. (2018) HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest 128:3102-3115
Lazar, Nellie Riendeau; Salas-Humara, Caroline; Wood, Sarah M et al. (2018) Missed Opportunities for HIV Screening Among a Cohort of Adolescents With Recently Diagnosed HIV Infection in a Large Pediatric Hospital Care Network. J Adolesc Health 63:799-802
Tawe, Leabaneng; Grover, Surbhi; Narasimhamurthy, Mohan et al. (2018) Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR. MethodsX 5:569-578
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Gowda, Charitha; Lott, Stephen; Grigorian, Matthew et al. (2018) Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5:ofy076

Showing the most recent 10 out of 775 publications